retatrutide type 2 diabetes phase 2 results 2024 ada Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, 3 Remission of type 2 diabetes:

Ozempic, a star GLP-1, steps onto the scene as a type 2 diabetes medication, preparing for its starring role in the SUSTAIN trials

A narrative synthesis approach was used to summarize findings across studies due to variability in study designs and outcome measures

What are some indicators that a patient with skin concerns after weight loss should be referred to a plastic surgeon

The EMA performs a similar function for medicines approved across the European Union

Post-cholecystectomy patients with certain genetic profiles may experience more pronounced gastrointestinal side effects or nutrient absorption challenges, supporting a case for more conservative dose titration or closer monitoring

CrossRef Liver-specific inactivation of Cideb improves metabolic profiles and ameliorates steatohepatitis and fibrosis in animal models for MASH Jianhua Zhang, Xujie Liu, Xian Jin, Xudong Mao, Xueli Xu, Xing Zhang, Ke Shang, Yuan Xu, Yanhuan Zhang, Guofeng Meng, Ming Yue, Guoqing Cai, Song Yang, Jinyu Huang, Jianwu Fang, Ling Pan, Lei Jiang, Stella Shi, Jianyong Shou Pharmacological Research .2025